In particular, one gene we discovered that was only associated with ER + BC was FGFR2, a receptor tyrosine kinase that is involved in cell growth and proliferation [54] that has been shown to contain several variants that associated with an increased risk of both ER + and overall BC [55–57]. This evidence concerns the gene NTRK1 and breast cancer.